HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eiji Oki Selected Research

Formaldehyde (Formol)

1/2023Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial.
10/2017Actionable gene-based classification toward precision medicine in gastric cancer.
1/2017Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma.
1/201612-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eiji Oki Research Topics

Disease

174Neoplasms (Cancer)
03/2024 - 12/2002
93Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 07/2008
85Stomach Neoplasms (Stomach Cancer)
02/2024 - 12/2002
41Neoplasm Metastasis (Metastasis)
06/2023 - 12/2007
32Esophageal Neoplasms (Esophageal Cancer)
06/2024 - 01/2008
29Colonic Neoplasms (Colon Cancer)
03/2024 - 05/2006
24Breast Neoplasms (Breast Cancer)
05/2023 - 01/2006
21Esophageal Squamous Cell Carcinoma
06/2023 - 08/2011
18Adenocarcinoma
10/2023 - 11/2015
15Carcinoma (Carcinomatosis)
06/2023 - 09/2005
14Rectal Neoplasms (Rectal Cancer)
03/2024 - 06/2006
13Microsatellite Instability
10/2021 - 09/2009
11Carcinogenesis
12/2020 - 08/2007
10Lymphatic Metastasis
06/2023 - 05/2013
10Neutropenia
01/2023 - 04/2013
8Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2023 - 08/2007
8Aneuploidy (Aneuploid)
06/2017 - 03/2010
6Chromosomal Instability (Chromosome Stability)
12/2020 - 03/2010
5Fatigue
06/2023 - 07/2014
5Disease Progression
01/2022 - 11/2013
5Inflammation (Inflammations)
12/2020 - 01/2014
4Pathologic Constriction (Stenosis)
11/2023 - 11/2013
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 04/2008
4Triple Negative Breast Neoplasms
01/2021 - 12/2010
3Hemorrhage
12/2023 - 05/2014
3Infections
09/2023 - 05/2015
3Febrile Neutropenia
12/2021 - 07/2014
3Melanoma (Melanoma, Malignant)
07/2020 - 01/2008

Drug/Important Bio-Agent (IBA)

38Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2024 - 01/2008
33Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2012
27DNA (Deoxyribonucleic Acid)IBA
03/2024 - 03/2008
27Bevacizumab (Avastin)FDA Link
02/2024 - 05/2013
23Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2008
21Fluorouracil (Carac)FDA LinkGeneric
10/2022 - 11/2003
19Irinotecan (Camptosar)FDA LinkGeneric
06/2023 - 11/2003
15trifluridine tipiracil drug combinationIBA
01/2024 - 04/2015
14Immune Checkpoint InhibitorsIBA
03/2024 - 03/2018
12ErbB Receptors (EGF Receptor)IBA
01/2023 - 01/2008
10Circulating Tumor DNAIBA
03/2024 - 01/2017
9Indicators and Reagents (Reagents)IBA
03/2024 - 12/2002
9Cetuximab (Erbitux)FDA Link
08/2023 - 05/2013
9Trastuzumab (Herceptin)FDA Link
05/2023 - 06/2006
9Capecitabine (Xeloda)FDA Link
10/2022 - 04/2013
9LigandsIBA
08/2021 - 07/2005
9Messenger RNA (mRNA)IBA
12/2020 - 05/2008
9Docetaxel (Taxotere)FDA Link
05/2019 - 11/2003
7Leucovorin (Folinic Acid)FDA Link
10/2022 - 01/2011
6Panitumumab (Vectibix)FDA Link
02/2024 - 05/2013
6Hormones (Hormone)IBA
05/2023 - 01/2006
6Trifluridine (Viroptic)FDA LinkGeneric
01/2023 - 12/2017
5Calcibiotic Root Canal SealerIBA
03/2024 - 10/2015
5Epidermal Growth Factor (EGF)IBA
02/2024 - 07/2005
5NivolumabIBA
10/2023 - 01/2019
5Monoclonal AntibodiesIBA
10/2023 - 01/2021
5ParaffinIBA
01/2023 - 01/2016
5Cisplatin (Platino)FDA LinkGeneric
02/2021 - 01/2017
5regorafenibIBA
06/2020 - 07/2015
4AntigensIBA
02/2024 - 10/2013
4Antineoplastic Agents (Antineoplastics)IBA
08/2023 - 11/2003
4Phosphotransferases (Kinase)IBA
07/2023 - 01/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 01/2017
4Formaldehyde (Formol)FDA Link
01/2023 - 01/2016
4RNA (Ribonucleic Acid)IBA
08/2021 - 12/2002
4B7-H1 AntigenIBA
06/2018 - 08/2016
4NucleotidesIBA
01/2017 - 03/2008
4Estrogen ReceptorsIBA
01/2017 - 05/2012
4Progesterone Receptors (Progesterone Receptor)IBA
01/2017 - 03/2007
4TensinsIBA
01/2015 - 09/2005
4Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
05/2013 - 07/2005
3CarbohydratesIBA
02/2024 - 11/2015
3pembrolizumabIBA
10/2023 - 10/2021
3Carcinoembryonic AntigenIBA
06/2023 - 11/2015
3Cadherins (E-Cadherin)IBA
08/2022 - 08/2015
3VimentinIBA
08/2022 - 12/2016
3RamucirumabIBA
01/2022 - 01/2018
3PlatinumIBA
01/2022 - 10/2015
3Tumor Biomarkers (Tumor Markers)IBA
10/2021 - 11/2015
3Oxygen (Dioxygen)IBA
09/2021 - 10/2013
3AntibodiesIBA
06/2021 - 08/2014
3Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2021 - 01/2018
3afliberceptIBA
11/2020 - 03/2019

Therapy/Procedure

81Therapeutics
10/2023 - 11/2005
62Drug Therapy (Chemotherapy)
03/2024 - 11/2003
35Gastrectomy
02/2024 - 01/2010
32Esophagectomy
06/2024 - 01/2008
29Adjuvant Chemotherapy
03/2024 - 11/2003
20Neoadjuvant Therapy
03/2024 - 09/2011
14Lymph Node Excision (Lymph Node Dissection)
09/2023 - 04/2008
10Immunotherapy
03/2024 - 01/2017
10Combination Drug Therapy (Combination Chemotherapy)
02/2021 - 04/2006
8Chemoradiotherapy
01/2021 - 11/2011
7Hepatectomy
09/2017 - 04/2011
7Liver Transplantation
08/2014 - 01/2009
5Radiotherapy
03/2024 - 01/2013
5Colectomy
03/2024 - 01/2014
5Length of Stay
12/2018 - 05/2014
4Lasers (Laser)
10/2018 - 10/2013
3Precision Medicine
03/2024 - 12/2016
3Gastroenterostomy
02/2024 - 01/2013
3Combined Modality Therapy
01/2021 - 12/2013